Stress Cardiac Magnetic Resonance of Asymptomatic Type 2 Diabetics with Cardiovascular High Risk to Measure Empagliflozin Impact on Myocardial Blood Flow (CATCH-EM)
ACTIVE_NOT_RECRUITING
Status
Conditions
- Type 2 Diabetes
- Microvascular Coronary Artery Disease
Interventions
- DRUG: Empagliflozin 10 MG
- DRUG: Placebo
- DIAGNOSTIC_TEST: Stress Cardiac Magnetic Resonance
Sponsor
The University of Hong Kong